Thalidomide in Treating Patients With Thyroid Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2001

Primary Completion Date

November 30, 2003

Study Completion Date

December 31, 2005

Conditions
Head and Neck Cancer
Interventions
DRUG

thalidomide

Trial Locations (1)

40536-0298

Albert B. Chandler Medical Center, University of Kentucky, Lexington

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Kenneth Ain

OTHER

NCT00026533 - Thalidomide in Treating Patients With Thyroid Cancer | Biotech Hunter | Biotech Hunter